Persistence of 18F-Fluciclovine uptake may signify the presence of tumour resistance to ADT, and upregulated tumoral expression of LAT1 following chronic ADT may at least in part mediate 18F-Fluciclovine uptake. This evidence concerns the gene SLC7A5 and neoplasm.